More research is needed to refine treatment strategies and identify predictive biomarkers for patient selection, according to researchers.

HealthDay News — A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & ...

Investigators sought to determine the safety and accuracy of remote cutaneous confocal microscopy vs histopathological diagnosis of melanoma and keratinocyte carcinoma.

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

Risk higher for women who gained more than 10 kg weight after 35 years of age versus those with stable weight.

Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

A CXB boost continues to provide an organ preservation benefit at 5 years, though there is some local regrowth after 3 years, researchers found.

Researchers found that the prices of cancer drugs in the US increased post-launch, but there was no such increase for non-cancer drugs.

Results of a retrospective study of a racially diverse population demonstrated positive outcomes for patients with NSCLC who experience irAEs when treated with immune checkpoint inhibitors.

Equecabtagene autoleucel produced “remarkable” responses in patients whose disease progressed after prior BCMA CAR T-cell therapy, researchers reported.

Mutation-directed targeted therapy in combination with a PD-L1 inhibitor “is a promising strategy” to extend survival in patients with anaplastic thyroid cancer, according to researchers.